Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin | PLOS ONE
![Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9dd30be94b40d1a5584ba467f720202997d10fdb/4-Table1-1.png)
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig1_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
![Early diagnosis of pancreatic cancer: Current trends and concerns - Hanada - 2017 - Annals of Gastroenterological Surgery - Wiley Online Library Early diagnosis of pancreatic cancer: Current trends and concerns - Hanada - 2017 - Annals of Gastroenterological Surgery - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/447c6b0d-8424-4e09-a597-1bea4c745ea2/ags312004-fig-0004-m.jpg)
Early diagnosis of pancreatic cancer: Current trends and concerns - Hanada - 2017 - Annals of Gastroenterological Surgery - Wiley Online Library
![Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer - ScienceDirect Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1365182X17311577-gr1.jpg)
Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer - ScienceDirect
![CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2001025641/2003896921/gr1.gif)